Ablynx

From Wikipedia, the free encyclopedia

Ablynx is a biotech company located in Ghent, Belgium. The foundation of the company is based on the work of Raymond Hamers and his team at the Vrije Universiteit Brussel (Brussels, Belgium), who discovered a special type of antibodies, called Nanobodies.

[edit] History

The company was founded in 2002 with support from the Flemish Interuniversity Institute of Biotechnology (VIB), in collaboration with founding venture investor, GIMV

[edit] External links

  This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../a/b/l/Ablynx.html"